Evidence map›Paper›PMID 30214562›Full record

ArticleOncology letters2018

Intensity-modulated radiation therapy combined with concomitant temozolomide for brain metastases from lung adenocarcinoma.

Jinli Li, Xiaoyan Chai, Ying Cao, Xiaochu Hu, Hongyu Zhu, Jianping Wang, Yiwei Wu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jinli LiDepartment of Radiation Oncology, The Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Xiaoyan ChaiDepartment of Oncology, Suzhou Science and Technology Town Hospital, Suzhou, Jiangsu 215153, P.R. China.
Ying CaoDepartment of Radiation Oncology, The Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Xiaochu HuDepartment of Radiation Oncology, The Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Hongyu ZhuDepartment of Radiation Oncology, The Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Jianping WangDepartment of Radiation Oncology, The Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Yiwei WuDepartment of Nuclear Medicine, The Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short-term efficacy, adverse effects and the impact on quality of life (QoL) of a concomitant treatment with intensity-modulated radiation therapy (IMRT) and temozolomide (TMZ) in patients with brain metastases (BMs) from lung adenocarcinoma were evaluated. This study sought to confirm the benefit of adding TMZ to IMRT in patients with BMs from lung adenocarcinoma. Nine patients were enrolled and received a dose of 30 Gy in 10 daily fractions to clinical tumor volume (CTV) according to IMRT, then additional dose of 9 Gy in 3 fractions of IMRT was delivered to gross tumor volume (GTV) only with concomitant TMZ (75 mg/m

Indexed as

brain metastasesintensity-modulated radiation therapylung adenocarcinomanon-small cell lung cancertemozolomide

Identifiers

PMID30214562
PMCPMC6126327
OpenAlexW2884125124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.